St. Jude Medical deals with medical technologies and enables to provide medication without risk by reducing these risk factors. The company employs up to 14000 labourers worldwide.
Epicor Cardiac Ablation Systems are products from St. Jude Medical, and high intensity focused ultrasounds are controlled and utilised in these systems to reproduce proven ablation lesion without the need for bypass machines. These products let the HIFU energies fall on the exterior of a beating heart, and these focused ultrasound energies accurately set ablates lesion to the complete thickness of atrial walls. These energies do not harm the tissues, which are close to atrial walls.
Epicor Cardiac Ablation Systems can be used for applications such as epicardial and off-pump, and they reduce up to five minutes of the general procedure time. They are utilised formerly in valve repairs, valve replacements or coronary artery bypass grafts. The UltraCinch is a component of ablation devices, which produces consistent, incessant lesions that are referred as box lesions. These lesions are created around all the four pulmonary veins in a single step during this ablation process. The cinch is placed over the patient's atrium and the transducers produce the HIFU energy, which is applied accurately to the affected tissues. Another device of these ablation systems is the UltraWand, which provides paired linear lesions.